Publications by authors named "Antonio Javier Jimenez Lopez"
Article Synopsis
- Opioid-induced constipation (OIC) affects up to 63% of cancer patients, prompting a study to evaluate the quality of life and effectiveness of naloxegol for those with OIC.
- An observational study involved 126 cancer patients who showed inadequate laxative response and were treated with naloxegol, using specific questionnaires to measure outcomes over three months.
- Results showed significant improvements in quality of life, increased bowel movements, and pain management after 15 days of treatment, with a good safety profile and only a small percentage experiencing mild to moderate gastrointestinal side effects.
We aimed to explore the characteristics, and real-life therapeutic management of patients with breakthrough cancer pain (BTcP) caused by bone metastases in Spain, and to evaluate physicians' opinion of and satisfaction with prescribed BTcP therapy. For the purposes of this study, an ad-hoc questionnaire was developed consisting of two domains: a) organizational aspects and care standards; b) clinical and treatment variables of bone metastatic BTcP patients. In addition, physicians' satisfaction with their prescribed BTcP therapy was assessed.
View Article and Find Full Text PDFObjectives: We aimed to generate expert-based recommendations on the management of breakthrough cancer pain (BTcP) in older patients with cancer.
Material And Methods: A two-round multidisciplinary Delphi study. Specialists rated their agreement with a set of statements using a nine-point Likert scale (one = totally disagree and nine = totally agree).
Evaluation of Quality of Life and Satisfaction of Patients with Neuropathic Pain and Breakthrough Pain: Economic Impact Based on Quality of Life.
Pain Res Treat
September 2018
Objective: The study objective was to assess the quality of life and satisfaction with treatment of patients with chronic neuropathic pain (CNP) who experience breakthrough pain (BTP) and to assess its economic impact.
Design: Cross-sectional observational study.
Setting: Fifteen pain units from Spanish hospitals completed the study.
Introduction: Breakthrough pain (BTP) has great repercussions on the quality of life, and on the use of health resources. The scope of BTP costs in cancer patients is unknown. The purpose of this study was to evaluate the economic cost of BTP in patients with cancer and the relationship with their quality of life.
View Article and Find Full Text PDFIntroduction: Although breakthrough dyspnea is very frequent in cancer patients, there are no precise recommendations for treating it. The main objective of this study was to analyze what treatments are used in clinical practice for the management of breakthrough dyspnea in cancer patients in Spain and the secondary objectives were to describe the characteristics of cancer patients with breakthrough dyspnea and the attributes of the disorder.
Methods: Cancer patients over 18 years of age, with breakthrough dyspnea and a Karnofsky performance score of ≥30, who were treated at departments of oncology in institutes across Spain were included in this cross-sectional observational study.